Condition
Uric Acid Concentration, Serum, Quantitative Trait Locus 7
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05601271Not ApplicableCompleted
Effect of Allopurinol on Markers of Mineral and Bone Metabolism
NCT06342180CompletedPrimary
Metabolic Differences Between Subtypes of Polycystic Ovary Syndrome
NCT04954560Not ApplicableCompletedPrimary
Effect of Losartan or Eprosartan on Fructose Hyperuricemia
Showing all 3 trials